VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $208,000 | -99.8% | 8,930 | -97.7% | 0.01% | -99.9% |
| Q2 2015 | $85,418,000 | +60.2% | 384,506 | +43.2% | 7.00% | +46.2% |
| Q1 2015 | $53,333,000 | +10.1% | 268,519 | -20.7% | 4.79% | -9.2% |
| Q4 2014 | $48,439,000 | +11.0% | 338,477 | +1.8% | 5.27% | +4.6% |
| Q3 2014 | $43,633,000 | +51.9% | 332,567 | +46.0% | 5.04% | +44.6% |
| Q2 2014 | $28,734,000 | -26.6% | 227,830 | -23.3% | 3.48% | -25.5% |
| Q1 2014 | $39,171,000 | – | 297,136 | – | 4.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |